Insights into antitrypanosomal drug mode-of-action from cytology-based profiling - Archive ouverte HAL Access content directly
Journal Articles PLoS Neglected Tropical Diseases Year : 2018

Insights into antitrypanosomal drug mode-of-action from cytology-based profiling

(1) , (2) , (3) , (4) , (5) , (3) , (1) , (5)
1
2
3
4
5

Abstract

Chemotherapy continues to have a major impact on reducing the burden of disease caused by trypanosomatids. Unfortunately though, the mode-of-action (MoA) of antitrypanosomal drugs typically remains unclear or only partially characterised. This is the case for four of five current drugs used to treat Human African Trypanosomiasis (HAT); eflornithine is a specific inhibitor of ornithine decarboxylase. Here, we used a panel of T. brucei cellular assays to probe the MoA of the current HAT drugs. The assays included DNA-staining followed by microscopy and quantitative image analysis, or flow cytometry; terminal dUTP nick end labelling to monitor mitochondrial (kinetoplast) DNA replication; antibody-based detection of sites of nuclear DNA damage; and fluorescent dye-staining of mitochondria or lysosomes. We found that melarsoprol inhibited mitosis; nifurtimox reduced mitochondrial protein abundance; pentamidine triggered progressive loss of kinetoplast DNA and disruption of mitochondrial membrane potential; and suramin inhibited cytokinesis. Thus, current antitrypanosomal drugs perturb distinct and specific cellular compartments, structures or cell cycle phases. Further exploiting the findings, we show that putative mitogen-activated protein-kinases contribute to the melarsoprol-induced mitotic defect, reminiscent of the mitotic arrest associated signalling cascade triggered by arsenicals in mammalian cells, used to treat leukaemia. Thus, cytology-based profiling can rapidly yield novel insight into antitrypanosomal drug MoA.
Fichier principal
Vignette du fichier
pntd.0006980.pdf (2.06 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

pasteur-03107158 , version 1 (12-01-2021)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

James Thomas, Nicola Baker, Sebastian Hutchinson, Caia Dominicus, Anna Trenaman, et al.. Insights into antitrypanosomal drug mode-of-action from cytology-based profiling. PLoS Neglected Tropical Diseases, 2018, 12 (11), pp.e0006980. ⟨10.1371/journal.pntd.0006980⟩. ⟨pasteur-03107158⟩

Collections

PASTEUR
13 View
37 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More